New studies presented at ACG 2026 indicate TissueCypher offers objective risk assessment for Barrett’s esophagus progression ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...
A novel DNA methylation test using the EndoSign capsule-sponge detected Barrett’s esophagus with 90% sensitivity and 86% ...
However, excessive consumption of carbonated drinks can harm esophageal health. A case from Vietnam has been reported ...
Cyted Health today announced positive clinical validation data from DETECT-ME, a prospective, multicenter study of the EndoSign® Barrett’s Esophagus (BE) Test. Conducted at 18 U.S. clinical sites, the ...
Cyted Health will present clinical validation data from DETECT-ME, a prospective, 18-site U.S. study of the EndoSign ® ...
Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and ...
This measured review examines potential links between long-term proton pump inhibitor use and dementia risk, urging ...
The reality star shares her concern that she could develop cancer after being diagnosed with a disease of her digestive tract ...
High-dose budesonide reduced esophageal stricture formation and the need for dilation after extensive ESD, although questions ...
Phathom Pharmaceuticals said Friday that BDR Pharmaceuticals International has sued the US Food and Drug Administration, or FDA, challenging its alleged refusal to accept a generic ...
Castle Biosciences, Inc. announced that new data from three studies evaluating its TissueCypher Barrett's Esophagus (BE) test will be presented at the American College of Gastroenterology (ACG) 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results